Archive for Medication updates
Class 3 Medicines Recall: Medreich PLC, Mebeverine hydrochloride 135mg Film-coated tablets, EL (22)A/46
Source: MHRA / Gov.uk 27.10.22 Medreich PLC UK is recalling a batch of Mebeverine hydrochloride 135mg film-coated tablets as a precautionary measure due to out of specification results for tablet...
Class 4 Medicines Defect Information: Recordati Rare Diseases, Pedea 5 mg/ml solution for injection, EL(22)A/45
Source: MHRA/ Gov.uk 25.10.22 Recordati Rare Diseases T/A Recordati Rare Diseases UK Ltd has made the MHRA aware that specific batches of Pedea 5 mg/ml solution for injection have been...
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma Limited t/a Sanofi, due to the presence of bacterial endotoxins, NatPSA/2022/008/MHRA
Source MHRA / Gov.uk 21.10.22 Sanofi UK is initiating an urgent recall of two batches of Targocid 200mg powder for solution for injection/infusion or oral solution ational Patient Safety Alert...
Price Concessions 2nd Update: October 2022
Source: DHSC/ NHSBSA Drug Tariff News – October Part VIIIA reimbursement prices (issued 20 October) The Department of Health and Social Care has agreed the October Drug Tariff Part VIIIA...
Class 2 Medicines Recall: hameln pharma ltd, Ephedrine Hydrochloride 30 mg/ml Solution for Injection, EL(22)A/44
Source: MHRA / Gov.uk 20.10.22 hameln pharma ltd is initiating a recall of the affected batches of Ephedrine Hydrochloride 30 mg/ml Solution for Injection as a precautionary measure. MDR number...
Parallel Import Profitability – October 2022 Update!
We have updated the Parallel Import Profitability tool with the latest October prices!! Members can click here to login & see the updates Looking to join Dispex, click here.
Price Concessions 1st Update: October 2022
Source: DHSC/ NHSBSA Drug Tariff News – October Part VIIIA reimbursement prices (issued 20 October) The Department of Health and Social Care has agreed the October Drug Tariff Part VIIIA...
Class 4 Medicines Defect Information: Flamingo Pharma UK Ltd, Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets), EL (22)A/43
Source: MHRA / Gov.uk 12.10.22 Flamingo Pharma UK Ltd has identified an error relating to the ink printing of the batch number and expiry date on the carton for three...
Class 2 Medicines Recall: hameln pharma ltd, Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion, EL (22)A/42
Source: MHRA / Gov.uk 11.10.22 hameln pharma ltd is initiating a recall of batch 210505 of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion as a precautionary measure MDR...
Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Stemetil 5mg/5ml Syrup, EL(22)A/41
Source: MHRA / Gov.uk 6.10.22 MDR number MDR 006-09/22 Company name Aventis Pharma Limited (t/a Sanofi) Product name Stemetil 5mg/5ml Syrup PL 04425/0595 Batch number Expiry date Pack size First...
Drug Tariff Update September 2022
Members’ Webpage- Drug Tariff Updates All prices are in pence CHANGES FOR SEPTEMBER ADDITIONS The following Additions to the Drug Tariff may be of interest to Dispensing Doctors Part VIIIA...
Price Concessions 3rd Update-September 2022
Source: NHSBSA / DHSC Drug Tariff News – September Part VIIIA reimbursement prices (issued 23 September) The Department of Health and Social Care has agreed the September Drug Tariff Part VIIIA reimbursement prices...
